125 related items for PubMed ID: 9663654
1. Inhibition of naloxone-stimulated adrenocorticotropin release by alprazolam in myotonic dystrophy patients.
Joyner JM, Grice JE, Hockings GI, Torpy DJ, Crosbie GV, Walters MM, Jackson RV.
J Neuroendocrinol; 1998 May; 10(5):391-5. PubMed ID: 9663654
[Abstract] [Full Text] [Related]
2. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
[Abstract] [Full Text] [Related]
3. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
[Abstract] [Full Text] [Related]
4. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
Vicennati V, Ceroni L, Gagliardi L, Pagotto U, Gambineri A, Genghini S, Pasquali R.
J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
[Abstract] [Full Text] [Related]
5. Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophy.
Grice JE, Jackson RV, Hockings GI, Torpy DJ, Walters MM, Crosbie GV.
J Clin Endocrinol Metab; 1995 Jan; 80(1):179-84. PubMed ID: 7829609
[Abstract] [Full Text] [Related]
6. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV.
Clin Exp Pharmacol Physiol; 1995 Jan; 22(6-7):441-3. PubMed ID: 8582096
[Abstract] [Full Text] [Related]
7. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
Buyalos RP, Jackson RV, Grice GI, Hockings GI, Torpy DJ, Fox LM, Boots LR, Azziz R.
J Clin Endocrinol Metab; 1998 Sep; 83(9):3219-24. PubMed ID: 9745431
[Abstract] [Full Text] [Related]
8. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ, Ellis MJ, Evans MJ, Donald RA.
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[Abstract] [Full Text] [Related]
9. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI, Ferries LM, Roberts B, Qualls CR, Veldhuis JD, Lisansky EJ.
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[Abstract] [Full Text] [Related]
10. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
Grottoli S, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, DeStefanis S, Camanni F, Ghigo E, Arvat E.
J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
[Abstract] [Full Text] [Related]
11. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans.
Arvat E, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, Broglio F, Camanni F, Ghigo E.
J Clin Endocrinol Metab; 1999 Aug; 84(8):2611-5. PubMed ID: 10443648
[Abstract] [Full Text] [Related]
12. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
[Abstract] [Full Text] [Related]
13. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
Alexander SL, Irvine CH.
Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
[Abstract] [Full Text] [Related]
14. Altered hypothalamic-pituitary-adrenal axis responsiveness in myotonic dystrophy: in vivo evidence for abnormal dihydropyridine-insensitive calcium transport.
Hockings GI, Grice JE, Crosbie GV, Walters MM, Jackson RV.
J Clin Endocrinol Metab; 1993 Jun; 76(6):1433-8. PubMed ID: 8388880
[Abstract] [Full Text] [Related]
15. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
Arvat E, Maccagno B, Ramunni J, Di Vito L, Gianotti L, Broglio F, Benso A, Deghenghi R, Camanni F, Ghigo E.
Neuroendocrinology; 1998 May; 67(5):310-6. PubMed ID: 9641612
[Abstract] [Full Text] [Related]
16. Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man.
Coiro V, Volpi R, Casti A, Maffei ML, Stella A, Volta E, Chiodera P.
Br J Clin Pharmacol; 2011 Jun; 71(6):951-5. PubMed ID: 21564163
[Abstract] [Full Text] [Related]
17. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[Abstract] [Full Text] [Related]
18. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV.
J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
[Abstract] [Full Text] [Related]
19. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
Grottoli S, Giordano R, Maccagno B, Pellegrino M, Ghigo E, Arvat E.
J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
[Abstract] [Full Text] [Related]
20. Paradoxical inhibition by aspirin of naloxone-induced adrenocorticotropin secretion in myotonic dystrophy.
Hockings GI, Jackson RV, Grice JE, Crosbie GV, Walters MM, Torpy DJ, Jackson AJ.
J Clin Endocrinol Metab; 1994 Jun; 78(6):1424-7. PubMed ID: 8200945
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
